infliksimab
Remicade, infliksimab
an anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis [protivnetno sredstvo, ki deluje proti TNF (tržno ime Remicade), sestavljeno iz protitelesa, usmerjenega proti TNF; daje se intravensko enkrat na mesec ali tri mesece; uporablja se pri zdravljenju Crohnove bolezni in revmatoidnega artritisa]
Dostopnost
Dostopnost